翡翠展覽會 EEX 深 滬
交易中 04-01 09:52:30 美东时间
4.56
+0.050
+1.11%
華盛通- 最 高4.6878
- 今 開4.51
- 成交量 3280股
- 最 低 4.56
- 昨 收 4.51
- 總市值 9.02亿
- 52周最高 5.42
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.305
- 委 比 33.77%
- 總股本 1.98亿
- 歷史最高 23.725
- 量 比 8.01
- 振 幅 2.83%
- 歷史最低 1.395
- 每 手 1
- 風險率 0.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Earnings Scheduled For March 13, 2026
Companies Reporting Before The Bell • Douglas Elliman (NYSE:DOUG) is likely to ...
03-13 19:11
Emerald Holding Sees FY2026 Sales $490.000M-$495.000M vs $493.650M Est
Emerald Holding (NYSE:EEX) sees FY2026 sales of $490.000 million-$495.000 million vs $493.650 million analyst estimate.
03-13 18:26
Emerald Holding Q4 EPS $(0.15) Misses $0.04 Estimate, Sales $132.700M Beat $131.150M Estimate
Emerald Holding (NYSE:EEX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $0.04 by 433.33 percent. This is a 600 percent decrease over earnings of $0.03 per share from the
03-13 18:25
Dow Tumbles More Than 700 Points: Investor Sentiment Declines, Fear & Greed Index In 'Extreme Fear' Zone
The CNN Fear & Greed Index rose to Extreme Fear zone as US stocks fell due to rising oil prices and concerns over Iran.
03-13 16:23
Adobe, Buckle And 3 Stocks To Watch Heading Into Friday
US stock futures mixed, potential focus on BKE, ADBE, EEX, ULTA, ZUMZ earnings. BKE up 0.5%, ADBE down 7.8%, EEX down 3.9%, ULTA down 8.4%, ZUMZ down 9.1%.
03-13 15:38
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
Rosenblatt Maintains Buy on Emerald Holding, Maintains $7.7 Price Target
Rosenblatt analyst Barton Crockett maintains Emerald Holding (NYSE:EEX) with a Buy and maintains $7.7 price target.
2025-12-17 20:26
Cementos Pacasmayo, Rezolve AI, Emerald Holding And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points o...
2025-12-16 23:53
Emerald Initiates Potential Strategic Options; Reiterates 2025 Revenue Guidance Between $460M To $465M
Emerald Holding, Inc. (NYSE: EEX) ("Emerald" or the "Company") announced that it has begun a review of potential strategic options following inquiries regarding a possible acquisition of the Company. Goldman Sachs &
2025-12-16 22:07
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
